Evaluation of Blood TMB for the Efficacy of Atezolizumab [BUDDY]
Status:
Recruiting
Trial end date:
2022-06-30
Target enrollment:
Participant gender:
Summary
This is single arm, prospective, multi-center, cohort study to evaluate blood TMB for
improved efficacy of atezolizumab in locally advanced or metastatic NSCLC at the study
enrollment who failed one or more prior lines of chemotherapy including at least 1
platinum-based.